↓ Skip to main content

Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
4 news outlets
policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches
Published in
Orphanet Journal of Rare Diseases, July 2020
DOI 10.1186/s13023-020-01462-0
Pubmed ID
Authors

Elena Nicod, Amanda Whittal, Michael Drummond, Karen Facey

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 15%
Student > Master 7 11%
Student > Ph. D. Student 6 9%
Other 5 8%
Student > Bachelor 5 8%
Other 6 9%
Unknown 27 41%
Readers by discipline Count As %
Medicine and Dentistry 9 14%
Pharmacology, Toxicology and Pharmaceutical Science 6 9%
Social Sciences 6 9%
Economics, Econometrics and Finance 5 8%
Nursing and Health Professions 3 5%
Other 8 12%
Unknown 29 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2023.
All research outputs
#1,098,711
of 23,917,011 outputs
Outputs from Orphanet Journal of Rare Diseases
#111
of 2,759 outputs
Outputs of similar age
#32,131
of 402,170 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#4
of 53 outputs
Altmetric has tracked 23,917,011 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,759 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,170 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.